Utilisation de l'épreuve immuno-enzymatique ELISA-NS3 pour différencier les chevaux infectés par le virus de la peste équine des chevaux vaccinés

OIE Revue Scientifique et Technique

Volumn 18, Issue 3, 1999, Pages 618-626

  Idrissi Bougrine, S ^a   Fassi Fihri, O ^a   El Harrak, M ^b   Fassi Fehri, M M ^a  

^a INSTITUT AGRONOMIQUE ET VÉTÉRINAIRE HASSAN II   (Morocco)

^b Laboratoire Bio Pharma   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS VACCINE;

AFRICAN HORSE SICKNESS VIRUS; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; HORSE; HORSE DISEASE; IMMUNOLOGY; SERODIAGNOSIS; VACCINATION;

AFRICAN HORSE SICKNESS; AFRICAN HORSE SICKNESS VIRUS; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HORSES; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; VACCINATION; VACCINES, INACTIVATED; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 0039255342     PISSN: 02531933     EISSN: None     Source Type: Journal    
DOI: 10.20506/rst.18.3.1179     Document Type: Article

References (14)

1. Burroughs J.N., O'Hara R.S., Smale C.J., Hamblin C., Walton A., Armstrong R. & Mertens P.P.C. (1994). -Purification and properties of virus particles, infectious sub-viral particles, cores and VP7 crystals of African horse sickness virus serotype-9. J. gen. Virol., 75, 1847-1849.
2. Dubourget P., Préaud J.M., Detraz N., Lacoste F., Fabry A.C., Erasmus B.J. & Lombard M. (1992). - Development, production, and quality control of an industrial inactivated vaccine against African horse sickness virus serotype 4. In Bluetongue, African horse sickness, and related orbiviruses. Proc. of the Second International Symposium (T.E. Walton & B.I. Osburn, édit.). CRC Press, Boca Raton, Floride, 874-886.
3. Grubman M.J. & Lewis S.A. (1992). - Identification and characterization of the structural and non structural proteins of African horse sickness virus and determination of the genome coding assignments. Virology, 186, 444-451.
4. Hess W.R. (1988). - African horse sickness. In Arboviruses: epidemiology and ecology (T.P. Monath, edit.). CRC Press, Boca Raton, Floride, 1-18.
5. House C., House J.A. & Mebus C.A. (1992). - A review of African horse sickness with emphasis on selected vaccines. Ann. N.Y. Acad. Sci., 653, 228-232.
6. House J.A. (1993). - Recommendations for African horse sickness vaccines for use in non endemic areas. Rev. Elev. Méd. vét. Pays trop., 46 (1-2), 77-81.
7. House J.A., Lombard M., Dubourget P., House C. & Mebus C.A. (1994). - Further studies on the efficacy of inactivated African horse sickness serotype-4 vaccine. Vaccine, 12 (1), 142-144.
8. Idrissi Bougrine S., Fassi Fihri O. & Fassi Fehri M.M. (1998). - Identification of African horse sickness virus protein-specific antibody responses in horses by immunoblotting and differentiation between infected and vaccinated horses. Arch. Virol., 14 (Suppl.), 329-336.
9. Laviada M.D., Arias M. & Sánchez-Vizcaíno J.M. (1993). -Characterization of African horse sickness virus serotype-4 induced polypeptides and their reactivity in Western immunoblotting. J. gen. Virol, 74, 81-87.
10. Laviada M.D., Roy P., Sánchez-Vizcaíno J.M. & Casal J.I. (1995). - The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horses. Virus Res., 38, 205-218.
11. Lhafi A., Tber A., Fikri A. & Laghzaoui K. (1992). - African horse sickness in Morocco: the epizootics of 1989 and 1990. In Bluetongue, African horse sickness, and related orbiviruses. Proc. of the Second International Symposium (T.E. Walton & B.I. Osburn, édit.). CRC Press, Boca Raton, Floride, 205-216.
12. Lubroth J. (1988). - African horse sickness and the epizootic in Spain, 1987. Equine Pract., 10, 26-33.
13. Martínez-Torrecuadrada J.L., Díaz-Laviada M., Roy P., Sánchez C., Vela C., Sánchez-Vizcaíno J.M. & Casal J.I. (1996). - Full protection against African horse sickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7. J. gen. Virol., 77, 1211-1221.
14. Roy P. & Sutton G. (1998). - New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles. Arch. Virol., 14 (Suppl.), 177-202.